The expression level of EHMT2, HNRNPL, EIF2S1, RRP8, FOXK1, CAD FOXK2, and MYBBP1A was significantly higher in cancer, while the expression of PPARGC1A was lower in liver cancer (Figure 9B). This evidence concerns the gene EHMT2 and cancer.